InvestorsHub Logo
Followers 4
Posts 372
Boards Moderated 0
Alias Born 08/13/2019

Re: Mr1979 post# 228958

Wednesday, 11/20/2019 5:58:11 PM

Wednesday, November 20, 2019 5:58:11 PM

Post# of 425885

Why would Gilead have a patent including Vascepa ? I don’t understand. Can you help me out here ?



If you are asking about the product, Gilead has a patent to treat non-alcoholic fatty liver disease using a compound or the compound combined with a peroxisome proliferator-activated receptor alpha (PPARa) agonist or fish oil.

Source: http://www.freepatentsonline.com/y2019/0134041.html

If you are asking why one company has another company's product in their patent, it's because patents grant the applicant with the right to EXCLUDE not the right to MAKE. For example, you are free to file a patent for a product that included Vascepa. If the patent were approved, that does not mean you could make the product (you would need a license from Amarin first), but it does prevent Amarin from manufacturing your patented product (google "patent trolls" for an example). Does that make sense?

In summary, I would not over interpret the inclusion of Vascepa in the patent. They use "fish oil" which could be Vascepa or DHA. I'm assuming they specifically refer to Vascepa by trade name because it's what they are using in their clinical trial (https://clinicaltrials.gov/ct2/show/NCT02781584?term=Vascepa&cond=NASH&draw=2&rank=2). Which again, is not indicative of anything because they could have obtained Vascepa on their own rather than through a partnership with Amarin.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News